Live Breaking News & Updates on Findings Demonstrated

Stay updated with breaking news from Findings demonstrated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company's First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today. ....

United Kingdom , Joseph Lobacki , Clinical Development Efforts , Prnewswire Artax Biopharma Inc , Findings Demonstrated , Investigational Agent , Well Tolerated , All Doses , Strongly Supports Further Clinical Development , Being Developed , Once Daily Oral Dosing , Address Autoimmune Diseases , Providing Immunomodulation , Officer Joseph , Artax Biopharma , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,